Accelerate Diagnostics Inc (AXDX)

Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.50% 2.921	3.027	3.299	2.921	2.812
Cost Of Revenue	8.19% 2.198	2.394	3.192	2.122	1.801
Gross Profit	14.22% 0.723	0.633	0.107	0.799	1.011
Operating Expenses	4.26% 10.88	11.36	14.76	13.38	17.07
Benefits Costs and Expenses	10.93% 17.15	15.46	2.258	35.50	19.61
Costs And Expenses	4.26% 10.88	11.36	14.76	13.38	17.07
Operating Income/Loss	5.35% -10.16	-10.73	-14.65	-12.59	-16.06
Nonoperating Income/Loss	139.08% -4.074	-1.704	15.69	-19.99	-0.733
Income/Loss From Continuing Operations Before Tax	14.44% -14.23	-12.43	1.041	-32.58	-16.80
Income Tax Expense/Benefit	100.00% -	0.564	0.131	0.156	-
Income/Loss From Continuing Operations After Tax	9.48% -14.23	-13.00	0.91	-32.73	-16.80
Net Income/Loss	9.48% -14.23	-13.00	0.91	-32.73	-16.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,645% 19.22	0.70	14.43	11.01	98.30
Diluted Average Shares	2,645% 19.22	0.70	14.55	11.01	98.30
Basic Earnings Per Share	8.64% -0.74	-0.81	0.06	-2.97	-0.17
Diluted Earnings Per Share	8.64% -0.74	-0.81	0.06	-2.97	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-